Transgenic mice depleted in a mature lymphocytic cell-type

Details Transgenic mice depleted in a mature lymphocytic cell-type Transgenic mice depleted in a mature lymphocytic cell-type

1997-07-24

2002-05-07

Martin, Jill D. (Department: 1632)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

Transgenic nonhuman animal

C800S013000, C800S009000, C800S011000, C800S021000, C800S022000, C800S025000, C435S455000, C435S463000, C435S320100

Reexamination Certificate

active

06384298

ABSTRACT:

FIELD OF THE INVENTION
The present invention relates to transgenic non-human animals wherein the mature form of at least one lymphocytic cell type is substantially depleted. More particularly, the invention relates to transgenic mice wherein mature T cells or plasma cells are depleted.
BACKGROUND OF THE INVENTION
The immune response is a complex defense system that is able to recognize and kill invading organisms such as bacteria, viruses, fungi and possibly also some types of tumor cells. The most characteristic aspects of the immune system are the specific recognition of antigens, the ability to discriminate between self and non-self antigens and a memory-like potential that enables a fast and specific reaction to previously encountered antigens. The vertebrate immune system reacts to foreign antigens with a cascade of molecular and cellular events that ultimately results in the humoral and cell-mediated immune response.
The major pathway of the immune defense commences with the trapping of the antigen by accessory cells such as dendritic cells or macrophages and subsequent concentration in lymphoid organs. There, the accessory cells present the antigen on their cell surface to subclasses of T cells classified as mature T helper cells. Upon specific recognition of the processed antigen the mature T helper cells can be triggered to become activated T helper cells. The activated T helper cells regulate both the humoral immune response by inducing the differentiation of mature B cells to antibody producing plasma cells and control the cell-mediated immune response by activation of mature cytotoxic T cells.
Naturally occurring processes sometimes result in the modulation of immune system cell types. Acquired immunodeficiency syndrome (AIDS) is a devastating infectious disease of the adult immune system which significantly affects cell-mediated immunity. This disease is manifested by profound lymphopenia which appears to be the result of a loss of T-lymphocytes which have the helper/inducer phenotype T4 as defined by the monoclonal antibody OKT4 (Fauci, A., et al. (1984)
Annals. Int. Med.
100, 92). Other clinical manifestations include opportunistic infections, predominantly
Pneumocystis carinii
pneumonia, and Karposi's sarcoma. Other disease states include Severe Combined Immuno Deficiency Syndrome (SCID) wherein T, B or both cell types may be depleted in humans. It is the existence of diseases affecting the immune system, such as AIDS and SCID, which has created the need for animal model systems to study the epitology and potential treatment of such disease states.
T lymphocytes recognize antigen in the context of self Major Histocompatibility Complex (MHC) molecules by means of the T cell receptor (TCR) expressed on their cell surface The TCR is a disulfide linked heterodimer noncovalently associated with the CD3 complex (Allison, J. P., et al. (1987)
Ann. Rev. Immunol.
5, 503). Most T cells carry TCRs consisting of &agr; and &bgr; glycoproteins. T cells use mechanisms to generate diversity in their receptor molecules similar to those operating in B cells (Kronenberg, M., et al. (1986)
Ann. Rev. Immunol.
4, 529; Tonegawa. S. (1983)
Nature
302, 575). Like the immunoglobulin (Ig) genes, the TCR genes are composed of segments which rearrange during T cell development. TCR and Ig polypeptides consist of amino terminal variable and carboxy terminal constant regions. The variable region is responsible for the specific recognition of antigen, whereas the C region functions in membrane anchoring and in transmitting of the signal that the receptor is occupied, from the outside to the inside of the cell. The variable region of the Ig heavy chain and the TCR &bgr; chain is encoded by three gene segments, the variable (V), diversity (D) and joining (J) segments. The Ig light chain and the TCR &agr; chain contain variable regions encoded by V and J segments only.
The V, D and J segments are present in multiple copies in germline DNA. The diversity in the variable region is generated by random joining of one member of each segment family. Fusion of gene segments is accompanied by insertion of several nucleotides. This N-region insertion largely contributes to the diversity, particularly of the TCR variable regions (Davis and Bjorkman (1986)
Nature
334, 395), but also implies that variable gene segments are often not functionally rearranged. The rearrangement of gene segments generallyoccurs at both alleles. However, T and B cells express only one TCR or Ig respectively and two functionally rearranged genes within one cell have never been found. This phenomenon is known as allelic exclusion.
During B development the rearrangement process starts at both heavy chain gene alleles. First a D segment is fused to a J segment followed by ligation of a V segment of the DJ join. If the VDJ joining is productive, further rearrangement of the other heavy chain allele is blocked, whereas rearrangement of the light chain loci is induced (Reth, M., et al. (1985)
Nature
317, 353).
In both B and T cells, partially (DJ) and completely (VDJ) rearranged genes reportedly are transcribed giving rise to two differently sized RNA molecules (Yancopoulos, G., et al. (1986)
Ann. Rev. Immunol.
4, 339; Born, W., et al. (1987)
TIG
3, 132). In B cells the DJ transcripts can be translated into a D&mgr;-chain, a truncated form of the Ig&mgr; heavy chain that lacks a V segment derived sequence. In general, that D&mgr;-chain is present in minor amounts, if at all. However, in one subclone (P4-11) of the 300-19 cell line, a transformed pre-B cell line which differentiates in vitro to Ig producing B cells, the expression of the D&mgr;-chain is reportedly very high (Reth, M., et al. (1985)
Nature
317, 353). This reference also reports that the heavy chain gene alleles in the P4-11 clone are blocked at the DJ rearrangement stage in cell culture and that such cells show a very high frequency of light chain gene rearrangements. This has led to the suggestion that the D&mgr; protein contains some of the regulatory determinales necessary for gene assembly (Yancopoulos, G., et al. (1986)
Ann. Rev. Immunol.
4, 339, 356).
Transgenic mice containing functionally rearranged Ig genes reportedly have been used in studying several aspects of Ig gene expression, e.g. tissue specific expression, the mechanism of segment rearrangement, allelic exclusion and repertoire development (Storb, U. (1987)
Ann. Rev. Immunol.
5, 151). It has also been reported that the transgenic heavy chain polypeptide only inhibits the complete VDJ rearrangement of endogenous heavy chain genes if it contains a transmembrane domain (Storb. 1987; Iglesias, A., et al. (1987)
Nature
330, 482; Nussenzweig, M., et al. (1987)
Science
236, 816; Nussenzweig, M., et al. (1988)
J. Exp. Med.
167, 1969).
Recently, the inventors reported that functionally rearranged TCR&bgr; genes can be appropriately expressed in transgenic mice (Krimpenfort, P., et al. (1988)
EMBO
7, 745). This functional TCR&bgr; chain gene prevents expression of endogenous &bgr; genes by inhibiting complete VDJ joining (Uematsu, Y., et al. (1988)
Cell
52, 831).
Two different types of T cells are involved in antigen recognition within the self MHC context. Mature T helper cells (CD4
+
CD8
−
) recognize antigen in the context of class II MHC molecules, whereas cytotoxic T cells (CD4
−
CD8
+
) recognize antigen in the context of class IMHC determinants (Swain, S. L. (1983)
Immun. Rev.
74, 129-142; Dialynas, P. D., et al. (1983)
Immun. Rev.
74, 29-56). It has been reported that class II- specific CD4
+
CD8
−
helper T cells (also referred to as T4 cells) fail to develop in mice neonatally treated with anti-class II MHC monoclonal antibody (Kruisbeek, A. M., et al. (1983)
J. Exp. Med.
157, 1932-1946; Kruisbeek, A. M., et al. (1985)
J. Exp. Med.
161, 1029-1047). Similarly, it has recently been reported that mice chronically treated with anti-class I MHC monoclonal antibody from birth have a significantly reduced population of CD4
−

Affiliated with

Also associated with

Rating

Transgenic mice depleted in a mature lymphocytic cell-type does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Transgenic mice depleted in a mature lymphocytic cell-type, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transgenic mice depleted in a mature lymphocytic cell-type will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2869030